HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Tellides Selected Research

Arteriosclerosis

1/2014SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function.
8/2012Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.
12/2011Activation of human vascular cells decreases their expression of transforming growth factor-beta.
8/2011AIP1 prevents graft arteriosclerosis by inhibiting interferon-γ-dependent smooth muscle cell proliferation and intimal expansion.
7/2010IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5.
9/2008Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.
3/2008Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.
9/2007Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.
6/2007Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis.
3/2007Interferon-gamma axis in graft arteriosclerosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Tellides Research Topics

Disease

14Inflammation (Inflammations)
01/2022 - 06/2005
14Atherosclerosis
11/2021 - 11/2006
12Arteriosclerosis
01/2014 - 03/2004
8Pathologic Constriction (Stenosis)
04/2022 - 09/2005
8Neointima
01/2017 - 08/2011
8Vascular Remodeling
11/2014 - 03/2004
6Aortic Aneurysm (Aneurysm, Aortic)
01/2022 - 01/2008
6Aneurysm (Aneurysms)
01/2022 - 09/2005
6Hyperplasia
01/2020 - 03/2004
6Coronary Artery Disease (Coronary Atherosclerosis)
02/2017 - 09/2006
5Atherosclerotic Plaque (Atheroma)
11/2021 - 01/2016
5Thoracic Aortic Aneurysm
01/2020 - 09/2005
4Aortic Diseases
01/2022 - 02/2014
4Williams Syndrome (Williams-Beuren Syndrome)
01/2017 - 10/2012
3Heart Diseases (Heart Disease)
01/2022 - 03/2009
3Fibrosis (Cirrhosis)
01/2021 - 01/2017
3Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
03/2016 - 10/2012
3Abdominal Aortic Aneurysm
11/2014 - 08/2005
2Hypertrophy
01/2022 - 01/2022
2Rupture
01/2022 - 01/2022
2Ischemia
01/2021 - 09/2013
2Hypoxia (Hypoxemia)
01/2021 - 09/2013
2Reperfusion Injury
11/2020 - 01/2004
2Aortic Dissection
04/2020 - 01/2016
2Thrombosis (Thrombus)
01/2019 - 01/2016
2Hemorrhage
01/2019 - 01/2016
2Cardiomyopathies (Cardiomyopathy)
11/2015 - 05/2012
2Cardiovascular Diseases (Cardiovascular Disease)
11/2015 - 12/2012
2Marfan Syndrome (Marfan's Syndrome)
02/2014 - 09/2012
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
08/2012 - 04/2006
2Heart Failure
05/2012 - 03/2007
1Aortic Valve Disease
04/2022
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
01/2022
1Aortic Rupture
01/2022
1False Aneurysm (Pseudoaneurysm)
01/2022
1Arteriovenous Fistula
01/2022
1Cardiomegaly (Heart Hypertrophy)
01/2022
1Hematoma
01/2022
1Disease Progression
11/2021
1Chronic Kidney Failure (Chronic Renal Failure)
07/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021
1Delayed Graft Function
11/2020

Drug/Important Bio-Agent (IBA)

11InterferonsIBA
11/2021 - 03/2004
8Proteins (Proteins, Gene)FDA Link
04/2022 - 09/2005
8Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 12/2011
8CytokinesIBA
01/2014 - 09/2005
7ElastinIBA
01/2022 - 10/2012
7Phenobarbital (Luminal)FDA Link
01/2017 - 03/2004
5Sirolimus (Rapamycin)FDA Link
01/2022 - 09/2007
5CollagenIBA
01/2022 - 04/2008
4Apolipoproteins E (ApoE)IBA
01/2022 - 10/2015
4LigandsIBA
03/2016 - 03/2007
4Interferon-gamma (Interferon, gamma)IBA
03/2012 - 03/2004
3RNA (Ribonucleic Acid)IBA
01/2021 - 07/2010
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2016 - 10/2015
3ChemokinesIBA
03/2012 - 06/2005
2Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 01/2016
2EnzymesIBA
11/2021 - 03/2012
2SolutionsIBA
01/2021 - 01/2021
2Interleukin-18 (Interleukin 18)IBA
11/2020 - 01/2007
2Nitric Oxide Synthase (NO Synthase)IBA
01/2019 - 01/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 03/2016
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2019 - 01/2008
2LipidsIBA
01/2019 - 01/2019
2MTOR InhibitorsIBA
01/2019 - 01/2017
2Fibronectins (Fibronectin)IBA
01/2019 - 10/2015
2IntegrinsIBA
01/2018 - 03/2016
2CalciumIBA
02/2017 - 05/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 02/2014
2Transforming Growth Factor-beta Type II ReceptorIBA
11/2014 - 02/2014
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2014 - 11/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 08/2010
2Small Interfering RNA (siRNA)IBA
05/2012 - 07/2010
2Interleukin-17 (Interleukin 17)IBA
03/2009 - 12/2008
2Interleukin-12 (IL 12)IBA
03/2007 - 01/2007
1NeuropilinsIBA
04/2022
1CalcineurinIBA
01/2022
1Angiotensin IIIBA
01/2022
1ActomyosinIBA
01/2022
1Metalloproteases (Metalloproteinases)IBA
01/2022
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2022
1cysteine and glycine-rich protein 3IBA
01/2022
1InflammasomesIBA
11/2021
1CholesterolIBA
11/2021
1DesmosterolIBA
11/2021
1SterolsIBA
11/2021
1Histone-Lysine N-MethyltransferaseIBA
01/2021
1Histones (Histone)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1A-factor (Streptomyces)IBA
11/2020
1AntibodiesIBA
11/2020
1Blood Group Antigens (Blood Groups)IBA
04/2020
1ABO Blood-Group SystemIBA
04/2020
11,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2020

Therapy/Procedure

8Transplantation
01/2021 - 01/2004
7Therapeutics
01/2022 - 03/2007
3Heart Transplantation (Grafting, Heart)
11/2015 - 03/2007
2Renal Dialysis (Hemodialysis)
01/2022 - 07/2021
2Organ Transplantation
08/2012 - 09/2008
1Bioreactors (Bioreactor)
01/2021